Edition:
United States

Dynasil Corporation of America (DYSL.OQ)

DYSL.OQ on NASDAQ Stock Exchange Capital Market

1.30USD
10:58am EDT
Change (% chg)

$-0.01 (-0.76%)
Prev Close
$1.31
Open
$1.30
Day's High
$1.30
Day's Low
$1.30
Volume
703
Avg. Vol
4,854
52-wk High
$2.04
52-wk Low
$1.09

Chart for

About

Dynasil Corporation of America is engaged in the development, marketing and manufacturing of detection, sensing and analysis technology and optical components, as well as contract research. The Company operates through three segments, including Contract Research, Optics and Biomedical. The Contract Research segment consists of... (more)
No analyst recommendations are available for .

Overall

Beta: 0.54
Market Cap(Mil.): $22.33
Shares Outstanding(Mil.): 17.18
Dividend: --
Yield (%): --

Financials

  DYSL.OQ Industry Sector
P/E (TTM): -- 39.22 32.53
EPS (TTM): -0.05 -- --
ROI: -5.21 14.34 12.63
ROE: -4.39 17.22 14.50

BRIEF-Dynasil Corporation Of America Reports Q2 EPS Of $0.08

* REPORTS SECOND QUARTER FISCAL 2018 NET INCOME OF $1.3 MILLION

May 14 2018

BRIEF-Dynasil Corporation Of America Q1 Loss Per Share $0.05

* Q1 LOSS PER SHARE $0.05 Source text for Eikon: Further company coverage:

Feb 13 2018

BRIEF-Dynasil Announces Submission Of Xcede Technologies' Application For First-In-Human Clinical Trial

* DYNASIL ANNOUNCES SUBMISSION OF XCEDE TECHNOLOGIES' APPLICATION FOR FIRST-IN-HUMAN CLINICAL TRIAL

Jan 11 2018

Competitors

Earnings vs. Estimates